|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/00 | |
| A61K 31/17 | |||
| A61K 31/435 | |||
| A61K 39/00 | |||
| G01N 33/50 | |||
| G01N 33/574 | |||
| A61K 38/18 | |||
| A61K 31/44 | |||
| A61K 39/395 | |||
| A61K 38/02 |
| (11) | Number of the document | 2726088 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12737394.2 |
| Date of filing the European patent application | 2012-06-28 | |
| (97) | Date of publication of the European application | 2014-05-07 |
| (45) | Date of publication and mention of the grant of the patent | 2019-01-02 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2012/044673 |
| Date | 2012-06-28 |
| (87) | Number | WO 2013/003606 |
| Date | 2013-01-03 |
| (30) | Number | Date | Country code |
| 201161502686 P | 2011-06-29 | US |
| (72) |
ANDERSON, Abraham, Antonio, US
WEINREICH, David, M., US
|
| (73) |
Amgen Inc.,
One Amgen Center Drive, Thousand Oaks, CA 91320-1799,
US
|
| (54) | PREDICTIVE BIOMARKER OF SURVIVAL IN THE TREATMENT OF RENAL CELL CARCINOMA |
| PREDICTIVE BIOMARKER OF SURVIVAL IN THE TREATMENT OF RENAL CELL CARCINOMA |